Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jean-Baptiste Meric"'
Autor:
B. Billemont, Eric Van Cutsem, David Khayat, Karen Soussan-Lazard, Sylvaine Cartot-Cotton, Olivier Rixe, Sabine Tejpar, Jean-Baptiste Meric, Sylvie Assadourian, Chris Verslype
Publikováno v:
European Journal of Cancer. 49:17-24
Background To determine dose-limiting toxicities (DLTs), recommended phase II trial dose (RPTD), safety, preliminary antitumour activity and pharmacokinetics of intravenous aflibercept with irinotecan, 5-fluorouracil and leucovorin (LV5FU2). Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cccb4579bc4928495637f5adc42f5906
https://doi.org/10.1016/j.ejca.2012.07.007
https://doi.org/10.1016/j.ejca.2012.07.007
Publikováno v:
Bulletin du Cancer. 97:S53-S63
New medical strategies have emerged over the past decade for the treatment of advanced renal cell carcinoma based on the discovery of specific molecular abnormalities. However, molecular targeted therapeutics including anti-angiogenics have demonstra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4556b6c07b8f712c4d00de4dcc238af
https://doi.org/10.1684/bdc.2010.1070
https://doi.org/10.1684/bdc.2010.1070
Autor:
Olivier Rixe, Laurent Taillade, Valentine Sultan-Amar, B. Billemont, Jean-Baptiste Meric, I. Alexandre
Publikováno v:
Bulletin du Cancer. 96:045-055
Angiogenesis or new blood vessel formation is a complex and fundamental event in the process of tumor growth and metastatic dissemination. Actually, most of antiangiogenic agents target the VEGF considered like the most potent proangiogenic factor. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79ac934a7c30ea8fa732fb5da873c990
https://doi.org/10.1684/bdc.2008.0775
https://doi.org/10.1684/bdc.2008.0775
Autor:
Christine Le Bihan Benjamin, Julien-Aymeric Simonnet, Mathieu Rocchi, Inès Khati, Estelle Ménard, Emilie Houas-Bernat, Jean-Baptiste Méric, Philippe-Jean Bousquet
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract The COVID-19 pandemic has had a substantial and lasting impact on care provision, particularly in the field of cancer care. National steering has helped monitor the health situation and adapt the provision and organisation of care. Based on
Externí odkaz:
https://doaj.org/article/e37c7e25e2754eadaf0d09762d9a12c4
Autor:
Catherine Dugast, Christelle Pruvost-Balland, Dan Lipsker, Nicolas Janin, Isabelle Coupier, Isabelle Mortemousque, Sophie Deveaux, Brigitte Gilbert-Dussardier, Laurence Faivre, Pierre Vabres, Emmanuel Van Glabeke, Hélène Dollfus, Min-Han Tan, Dominique Leroux, Pierre Rustin, Bernard Escudier, Marie-Françoise Avril, Joelle Roume, Veronica Cusin, Virginie Verkarre, Johny Bombled, Luc Thomas, Felicia Malthieu, Betty Gardie, Jean Feunteun, Darouna Kattygnarath, Jean -Baptiste Meric, Arnaud Mejean, Ghislaine Plessis, Olivier Caron, Victoria Perrier-Trudova, Stéphane Richard, Frédéric Caux, Virginie Joulin, Gilbert M. Lenoir, Abdelhamid Slama, Christine Maugard, Serena Rooker, Michel Barrois, Sandrine Lefevre, Brigitte Bressac-de Paillerets, Audrey Remenieras, Christine Theodore, Didier Bessis, Michelle Steinraths, Michel Field, Bruce Poppe, Yves Leport, Carol Cremin, Patrick Collignon, Barbara McGilliwray, Nadem Soufir, Bin Tean Teh
Publikováno v:
Journal of Medical Genetics
Journal of Medical Genetics, BMJ Publishing Group, 2011, 48 (4), pp.226. ⟨10.1136/jmg.2010.085068⟩
Journal of Medical Genetics, 2011, 48 (4), pp.226. ⟨10.1136/jmg.2010.085068⟩
Journal of Medical Genetics, BMJ Publishing Group, 2011, 48 (4), pp.226. ⟨10.1136/jmg.2010.085068⟩
Journal of Medical Genetics, 2011, 48 (4), pp.226. ⟨10.1136/jmg.2010.085068⟩
International audience; Background Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant disorder predisposing humans to cutaneous and uterine leiomyomas; in 20% of affected families, type 2 papillary renal cell cancers (PR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::708f403f1114b76553e7bb7a5763694a
https://hal.archives-ouvertes.fr/hal-00614499/file/PEER_stage2_10.1136%2Fjmg.2010.085068.pdf
https://hal.archives-ouvertes.fr/hal-00614499/file/PEER_stage2_10.1136%2Fjmg.2010.085068.pdf
Autor:
Jean-Baptiste, Meric
Publikováno v:
Bulletin du cancer. 94
Colorectal cancers have been the first cancers to benefit from an efficient anti-angiogenic treatment, represented by bevacizumab, which has been approved for first-line metastatic treatment in combination with reference chemotherapies and which is u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7446afffc30778946d9ef2741567736f
https://pubmed.ncbi.nlm.nih.gov/17964998
https://pubmed.ncbi.nlm.nih.gov/17964998
Autor:
Olivier Rixe, Jean -Baptiste Meric, Sylvie Rottey, Jean Philippe Spano, David Khayat, Ken A. Olaussen, Jean-Charles Soria
Publikováno v:
Critical reviews in oncology/hematology. 59(1)
The two isoforms cyclooxygenase-1 and -2 catalyze the initial step in the formation of prostaglandins in a variety of pathophysiological processes. More recently their role in carcinogenesis has become more evident. They seem to influence apoptosis,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13439208929c10838fd6496a2938971d
https://pubmed.ncbi.nlm.nih.gov/16531064
https://pubmed.ncbi.nlm.nih.gov/16531064
Publikováno v:
Melanoma research. 15(3)
Biological response parameters during biochemotherapy, including chemotherapy with immune modulating agents, have been studied extensively. Of these parameters, interleukin-6 (IL-6) has been implicated in advanced stage disease and tumour recurrence.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a022ca0c79201c21f24d83ea610bf49d
https://pubmed.ncbi.nlm.nih.gov/15917702
https://pubmed.ncbi.nlm.nih.gov/15917702
Autor:
Michel Daudon, Anne Bissery, Alain Mallet, Pierre Conort, Raphaëlle Renard-Penna, Marie-France Bellin, Philippe Grenier, Jean-Baptiste Meric, François Richard
Publikováno v:
European radiology. 14(11)
The aim of this study was to evaluate the efficacy of helical CT using a combination of CT-attenuation values and visual assessment of stone density as well as discriminant linear analysis to predict the chemical composition of urinary calculi. One h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9600e257f4012f81c534e3a0101dac82
https://pubmed.ncbi.nlm.nih.gov/15221262
https://pubmed.ncbi.nlm.nih.gov/15221262